Award
Delivery Order #SPE2DR26F8FL1
AmerisourceBergen Drug Corp Receives Delivery Order for Fluticasone Medication
Buyer
Defense Logistics Agency
Award Amount
$1,091.25
Ceiling
$1,091.25
Awarded
February 13, 2026
Period of Performance
Feb 13, 2026 – Feb 17, 2026
Identifier
SPE2DR26F8FL1
NAICS
424210
This award represents a delivery order contract under an established indefinite delivery vehicle (IDV) agreement with AmerisourceBergen Drug Corp, a leading pharmaceutical distributor specializing in medication supply and related healthcare services. The contract procures a specific pharmaceutical product, Fluticasone Propionate HFA, a topical inhalation medication used to treat respiratory conditions. This delivery order is significant as it supports the agency’s ongoing efforts to maintain essential medication availability for healthcare facilities, ensuring timely and reliable distribution. The scope involves the provision and delivery of this medication to a designated location in Pennsylvania within a short performance window. The award follows a competitive process under the broader IDV contract awarded previously to AmerisourceBergen, reflecting a streamlined procurement strategy for pharmaceutical products. The timeline for this delivery order is brief, covering a period of several days in early 2026, fitting within the longer-term IDV contract framework that spans over a decade.
Description
4570833197!FLUTICASONE PROP HFA 44 MCG 10.6GM